Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.8187
Delayed Data
As of May 21
 -0.0213 / -2.54%
Today’s Change
0.51
Today|||52-Week Range
3.72
+16.97%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 0.96, with a high estimate of 0.96 and a low estimate of 0.96. The median estimate represents a +17.26% increase from the last price of 0.82.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$0.00
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.05%
 
 
 
 
 
 
Growthannually -7.87%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account